drugset / Trial / NCT01837069

Risk Factor Control Before Orthopedic Surgery

NCT01837069

Phase 4 Terminated 198 enrolled NYU Langone Health
RandomizedParallel-groupOpen-labelPrevention

Summary

This trial is designed to determine the best preoperative management strategy for patients undergoing orthopedic surgery.

Timeline

Start
2014-02
Primary completion
2018-04-02
Completion
2018-04-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 80 mg Oral
Comparator LISINOPRIL ANHYDROUS Small molecule 2.5 mg Oral
Comparator Metoprolol Other / unclassified 25 mg Oral